Express Pharma

CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process development and a phase-I clinical trial

0 180